Suppr超能文献

营利性与非营利性独立肾脏透析机构的透析服务提供情况。

The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities.

作者信息

Griffiths R I, Powe N R, Gaskin D J, Anderson G F, de Lissovoy G V, Whelton P K

机构信息

Division of Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

出版信息

Health Serv Res. 1994 Oct;29(4):473-87.

Abstract

OBJECTIVE

A study was conducted to determine whether for-profit and not-for-profit freestanding renal dialysis facilities differ with respect to efficiency in the production of dialysis treatments.

DATA SOURCES/STUDY SETTING: National data on 1,224 Medicare-certified freestanding dialysis facilities were obtained from the Health Care Financing Administration's (HCFA) 1990 Independent Renal Dialysis Facility Cost Report. Data on Medicare patients receiving care at these facilities during 1990 were obtained from HCFA's End Stage Renal Disease (ESRD) Program Management and Medical Information System (PMMIS).

STUDY DESIGN

Ordinary least squares regression (OLS) was used to estimate the association between monthly output of dialysis treatments in 1990 and (a) facility capital and labor inputs, (b) facility ownership characteristics, and (c) case-mix characteristics.

DATA COLLECTION/EXTRACTION METHODS: Facility and patient level data were extracted from the Facility Cost Report and the PMMIS databases, respectively. Patient level data were aggregated by facility and merged with facility level data.

PRINCIPAL FINDINGS

For-profit sole proprietorships, for-profit partnerships and for-profit corporations each produced significantly more dialysis treatments per month than not-for-profits, adjusting for quantities of resource inputs and case-mix characteristics.

CONCLUSION

For-profit facilities appear to be more efficient producers of dialysis treatments than not-for-profits. Further study should address whether other factors such as differences in severity of disease or in quality of care are responsible for these observations.

摘要

目的

开展一项研究以确定营利性和非营利性独立肾脏透析机构在透析治疗生产效率方面是否存在差异。

数据来源/研究背景:关于1224家获得医疗保险认证的独立透析机构的全国性数据,取自医疗保健财务管理局(HCFA)1990年的独立肾脏透析机构成本报告。1990年在这些机构接受治疗的医疗保险患者的数据,取自HCFA的终末期肾病(ESRD)项目管理与医疗信息系统(PMMIS)。

研究设计

采用普通最小二乘法回归(OLS)来估计1990年透析治疗月产量与以下因素之间的关联:(a)机构资本和劳动力投入;(b)机构所有权特征;(c)病例组合特征。

数据收集/提取方法:机构层面和患者层面的数据分别从机构成本报告和PMMIS数据库中提取。患者层面的数据按机构进行汇总,并与机构层面的数据合并。

主要发现

在对资源投入量和病例组合特征进行调整后,营利性独资企业、营利性合伙企业和营利性公司每月生产的透析治疗量均显著高于非营利性机构。

结论

营利性机构似乎比非营利性机构在透析治疗生产方面更具效率。进一步的研究应探讨诸如疾病严重程度差异或护理质量差异等其他因素是否导致了这些观察结果。

相似文献

5
Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.
JAMA. 2007 Apr 18;297(15):1667-74. doi: 10.1001/jama.297.15.1667.
6
Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation.
N Engl J Med. 1999 Nov 25;341(22):1653-60. doi: 10.1056/NEJM199911253412205.
7
For-profit versus not-for-profit dialysis care for children with end stage renal disease.
Pediatrics. 1999 Sep;104(3 Pt 1):519-24. doi: 10.1542/peds.104.3.519.
9
Reexploring differences among for-profit and nonprofit dialysis providers.
Health Serv Res. 2010 Jun;45(3):633-46. doi: 10.1111/j.1475-6773.2010.01103.x. Epub 2010 Apr 9.
10

引用本文的文献

1
Impact of the End Stage Renal Disease Prospective Payment System on the Use of Peritoneal Dialysis.
Kidney Int Rep. 2016 Dec 20;2(3):350-358. doi: 10.1016/j.ekir.2016.12.004. eCollection 2017 May.
2
For-profit status and industry evolution in health care markets: evidence from the dialysis industry.
Int J Health Econ Manag. 2016 Dec;16(4):297-319. doi: 10.1007/s10754-016-9192-6. Epub 2016 Jul 14.
3
Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities.
Clin J Am Soc Nephrol. 2014 Jan;9(1):73-81. doi: 10.2215/CJN.04200413. Epub 2013 Dec 26.
4
Variation in dialysis quality measures by facility, neighborhood, and region.
Med Care. 2013 May;51(5):413-7. doi: 10.1097/MLR.0b013e318287d720.
5
The effect of dialysis chains on mortality among patients receiving hemodialysis.
Health Serv Res. 2011 Jun;46(3):747-67. doi: 10.1111/j.1475-6773.2010.01219.x. Epub 2010 Dec 9.
6
Predictors of chain acquisition among independent dialysis facilities.
Health Serv Res. 2010 Apr;45(2):476-96. doi: 10.1111/j.1475-6773.2010.01081.x. Epub 2010 Feb 9.
7
A 12-year analysis of Malmquist total factor productivity in dialysis facilities.
J Med Syst. 2006 Oct;30(5):333-42. doi: 10.1007/s10916-005-9005-9.
8
Longitudinal analysis of efficiency in multiple output dialysis markets.
Health Care Manag Sci. 2004 Nov;7(4):253-61. doi: 10.1007/s10729-004-7534-2.
10
Patients, populations and policy: patient outcomes in chronic kidney disease.
Trans Am Clin Climatol Assoc. 2001;112:224-32; discussion 232-4.

本文引用的文献

1
End-stage renal disease: a profile of facilities furnishing treatment.
Health Care Financ Rev. 1984 Winter;6(2):87-90.
3
Competition and efficiency in the end stage renal disease program.
J Health Econ. 1983 Aug;2(2):95-118. doi: 10.1016/0167-6296(83)90001-2.
4
Profit and the end-stage renal-disease program.
N Engl J Med. 1981 Aug 20;305(8):461-2. doi: 10.1056/nejm198108203050814.
5
The success of medicare's end-stage renal-disease program: the case for profits and the private marketplace.
N Engl J Med. 1981 Aug 20;305(8):434-8. doi: 10.1056/NEJM198108203050805.
7
Investor-owned hospitals and health-care costs.
N Engl J Med. 1983 Aug 11;309(6):370-2. doi: 10.1056/NEJM198308113090609.
10
The Medicare cost of renal dialysis. Evidence from a statistical cost function.
Med Care. 1992 Oct;30(10):879-91. doi: 10.1097/00005650-199210000-00001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验